Yung H. Chyung

Chief Medical Officer, Scholar Rock Holding Corp.

Companies

Keros Therapeutics, Inc.Chief Medical Officer Nov 8, 2024 to now¹
Tourmaline Bio, Inc.Chief Medical Officer Oct 23, 2023 to Oct 23, 2023²
Scholar Rock Holding CorpChief Medical Officer May 23, 2018 to Feb 15, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Scholar Rock Holding Corp SRRK258,496 shares⁴$10.5M at $40.78Feb 14, 2022
Keros Therapeutics, Inc. KROS44,000 shares⁵$485.8K at $11.04Feb 18, 2025
Tourmaline Bio, Inc.56,836 shares⁶Oct 19, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 18, 2025Granted 44,000 shares of Keros Therapeutics, Inc.⁵
Oct 19, 2023Granted 56,836 shares of Tourmaline Bio, Inc.⁶
Feb 14, 2022Granted 37,500 shares of Scholar Rock Holding Corp⁴
Jan 18, 2022Shares withheld for tax 1,421 shares at $19.46 of Scholar Rock Holding Corp⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKeros Therapeutics, Inc., Chief Medical Officer
2
SEC EDGARTourmaline Bio, Inc., Chief Medical Officer
3
SEC EDGARScholar Rock Holding Corp, Chief Medical Officer
4
SEC EDGARScholar Rock Holding Corp shares after the filing of Feb 14, 2022
5
SEC EDGARKeros Therapeutics, Inc. shares after the filing of Feb 18, 2025
6
SEC EDGARTourmaline Bio, Inc. shares after the filing of Oct 19, 2023
7
SEC EDGARForm 4 filed Jan 19, 2022